Zhejiang Hisun Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biological and generic drugs in China. The company provides active pharmaceutical ingredients. It also offers its products for anti-tumor, anti-infection, cardiovascular, endocrine, immunosuppression, antidepressant, and orthopedics treatment; nutrition and healthcare; and oncology, ADC small molecule, animal healthcare, and others. The company exports its products to approximately 70 countries worldwide. Zhejiang Hisun Pharmaceutical Co., Ltd. was founded in 1956 and is headquartered in Taizhou, China.
Frequently asked questions
What sector does Zhejiang Hisun Pharmaceutical Co Ltd (600267) operate in?
Zhejiang Hisun Pharmaceutical Co Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Zhejiang Hisun Pharmaceutical Co Ltd (600267) current stock price?
As of the latest data, Zhejiang Hisun Pharmaceutical Co Ltd stock price is CN¥11.26, with a previous close of CN¥11.61. Zhejiang Hisun Pharmaceutical Co Ltd lost -CN¥0.35 in the last trading session, representing a -3.01% loss.
What is Zhejiang Hisun Pharmaceutical Co Ltd (600267) current market capitalization?
Zhejiang Hisun Pharmaceutical Co Ltd market cap is approximately 13.29 billion.
What is Zhejiang Hisun Pharmaceutical Co Ltd (600267) Earnings Per Share (EPS)?
The trailing EPS is CN¥0.75, and the forward EPS is CN¥0.54.
What is Zhejiang Hisun Pharmaceutical Co Ltd (600267) Price-to-Earnings (P/E) ratio?
Zhejiang Hisun Pharmaceutical Co Ltd current P/E ratio is 15.01, with a forward P/E of 20.85.
Does Zhejiang Hisun Pharmaceutical Co Ltd (600267) pay dividends?
No. Zhejiang Hisun Pharmaceutical Co Ltd does not pay a dividend.
What is Zhejiang Hisun Pharmaceutical Co Ltd (600267) beta (volatility) score?
Zhejiang Hisun Pharmaceutical Co Ltd has a beta of 0.278, indicating lower volatility than the overall market.
